Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Weekly Stock Review: MaiDe Medical (688310) repurchased shares worth 25.64 million yuan, accounting for 0.96% of the total share capital.
As of the close on April 3, 2026, Mindray Medical (688310) closed at 14.76 yuan, down 3.47% from last week’s 15.29 yuan. This week, Mindray Medical’s intraday high on April 1 was 15.74 yuan. On April 3, the intraday low was 14.52 yuan. Mindray Medical’s current latest total market value is 2.45B yuan; in the automation equipment sector it ranks 75/79 by market value, and in the A-share market across both cities it ranks 4855/5193 by market value.
Key focus this week
Company announcement roundup
Mindray Medical Industrial Equipment Co., Ltd. first disclosed its share repurchase plan on December 13, 2025. The repurchase period runs from December 30, 2025 to December 29, 2026. The company plans to repurchase an amount of 20 million yuan to 40 million yuan, to reduce registered capital. As of March 31, 2026, the company has cumulatively repurchased 1,600,082 shares, accounting for 0.9626% of the total share capital, with a cumulative payment of 25,639,888.96 yuan. The repurchase price range was 15.69 yuan/share to 16.50 yuan/share. In March 2026 alone, it repurchased 303,030 shares, and paid 4,979,684.17 yuan. This repurchase complies with relevant regulations and the company’s plan requirements.
The above content has been compiled by Securities Star from publicly available information and generated by an AI algorithm (网信算备310104345710301240019号); it does not constitute investment advice.